Marlin Equity Partners, a private equity firm based in the United States, completed an investment in Intelligent Locations, a healthcare technology company also headquartered in the US. The transaction was announced on October 14, 2025.
| Acquirer | Marlin Equity Partners (US) |
| Target | Intelligent Locations (US) |
| Type | Growth Investment |
| Value | Undisclosed |
| Date of Close | October 14, 2025 |
| Buy-Side Advisors | First Analysis Securities Corporation |
| Sell-Side Advisors | Not Disclosed |
| Legal (Buy-side) | Goodwin Procter |
| Legal (Sell-side) | Bass Berry & Sims |
Marlin Equity Partners made a growth investment in Intelligent Locations, aiming to further invest in the company's AI-powered INTRAXTM platform. The deal will help continue leveraging artificial intelligence to optimize clinical operations for healthcare customers.
Deal Rationale:
The acquisition supports Marlin Equity Partners' strategy to enhance its portfolio companies' capabilities through technology-driven solutions. Specifically, the investment in Intelligent Locations aims to bolster the company's INTRAXTM platform, which uses AI to streamline and improve clinical operations for healthcare organizations.
Financial Context:
The exact value of Marlin Equity Partners' investment was not disclosed. However, the transaction underscores the growing importance of artificial intelligence in enhancing operational efficiencies within the healthcare sector.
Outlook:
This investment is expected to drive further innovation and expansion for Intelligent Locations as it continues to develop its INTRAXTM platform under Marlin Equity Partners' support. The partnership aims to leverage advanced technology solutions to address key challenges in healthcare delivery.